Vergleich

dagrocorat

ArtNr V4491-25mg
Hersteller InvivoChem LLC
CAS-Nr. 1044535-52-5
Menge 25 mg
Quantity options 10 mg 1 mg 50 mg
Kategorie
Typ Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Lieferbar
Description
InvivoChem Cat #:V4491CAS #:1044535-52-5Purity >=98%

Description: Dagrocorat (also known as PF-00251802) is a novel and potent dissociated glucocorticoid receptor agonist with the potential usefulness as an anti-inflammatory agent. The dissociated agonists of the glucocorticoid receptor are a novel class of agents in clinical development for rheumatoid arthritis. PF-04171327 (fosdagrocorat) is a phosphate ester prodrug of PF-00251802 (dagrocorat), a selective high-affinity partial agonist of the glucocorticoid receptor, which is further metabolized to PF-04015475. PF-00251802 is a reversible inhibitor of several CYPs, but modeling has suggested no clinically relevant interaction. PF-00251802 and PF-04015475 are time-dependent inhibitors and inducers of CYP3A in vitro; PF-00251802 is also a time-dependent inhibitor of CYP2D6. Model-based prediction suggested the potential for weak inhibition of CYP3A in vivo. A clinical DDI study was conducted with midazolam, a sensitive CYP3A substrate. A phase 1 open-label, multiple-dose study evaluated the effect of PF-04171327 on midazolam pharmacokinetics and safety in 12 healthy volunteers. Administration of midazolam alone or concomitantly with PF-04171327 resulted in equivalent pharmacokinetic profiles (AUCinf , 21.17 vs 20.28 ng·h/mL, respectively), indicating that PF-04171327 had no net effect on CYP3A activity in vivo. These findings support the further development of PF-00251802 and PF-04171327 as potential treatments for patients with rheumatoid arthritis (NCT00987038).

References: 2018 Mar; 7(3):244-255.

Related CAS: 1044535-58-1 (Fosdagrocorat)

Dagrocorat

Name: Dagrocorat
CAS#: 1044535-52-5
Chemical Formula: C29H29F3N2O2
Exact Mass: 494.2181
Molecular Weight: 494.5582
Elemental Analysis: C, 70.43; H, 5.91; F, 11.52; N, 5.66; O, 6.47
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Technical Information
Synonym: PF-251802; PF 251802; PF251802; PF-00251802; PF 00251802; PF00251802;
IUPAC/Chemical Name: (4bR, 7S, 8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b, 5, 6, 7, 8, 8a, 9, 10-octahydrophenanthrene-2-carboxamide
InChi Key: QJJBNCHSWFGXML-QPVYNBJUSA-N
InChi Code: InChI=1S/C29H29F3N2O2/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(36, 29(30, 31)32)14-13-27(23, 24)17-20-6-3-2-4-7-20/h2-8, 10, 12, 15-16, 23, 36H, 9, 11, 13-14, 17-18H2, 1H3, (H, 34, 35)/t23-, 27-, 28+/m1/s1
SMILES Code: FC([C]1(O)CC[C]2(CC3=CC=CC=C3)C4=CC=C(C(NC5=CC=CN=C5C)=O)C=C4CC[C]2([H])C1)(F)F

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 25 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen